⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SPRY News
ARS Pharmaceuticals, Inc. Common Stock
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
SPRY DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
Faruqi & Faruqi, LLP Urges ARS Pharmaceuticals (SPRY) Investors to Seek Counsel Before the October 5, 2026 Lead Plaintiff Deadline in the Securities Class Action Ready to Announce with Confidence?
newsfilecorp.com
SPRY
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 – ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Investors Urged to Contact Levi & Korsinsky for Information Before October 5, 2026 – ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
Class Action Lawsuit Reminder from Pomerantz LLP for Shareholders of ARS Pharmaceuticals, Inc. – SPRY
accessnewswire.com
SPRY
Contact Levi & Korsinsky by October 5, 2026 to Join Class Action Against ARS Pharmaceuticals, Inc. (SPRY)
accessnewswire.com
SPRY
SPRY DEADLINE: ROSEN, REGARDED INVESTOR COUNSEL, Encourages ARS Pharmaceuticals, Inc. Investors to Secure Counsel Before Important October 5 Deadline in Securities Class Action - SPRY
accessnewswire.com
SPRY
ARS Pharmaceuticals, Inc. (SPRY) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 5, 2026 Deadline
accessnewswire.com
SPRY